[HTML][HTML] Phase I–IV Drug Trials on Hepatocellular Carcinoma in Asian Populations: A Systematic Review of Ten Years of Studies
A Raghav, GB Jeong - International Journal of Molecular Sciences, 2024 - mdpi.com
Despite advances in the treatment of hepatocellular carcinoma (HCC) over the last few
decades, treatment opportunities for patients with HCC remain limited. HCC is the most …
decades, treatment opportunities for patients with HCC remain limited. HCC is the most …
Insights in Molecular Therapies for Hepatocellular Carcinoma
P Heumann, A Albert, K Gülow, D Tümen, M Müller… - Cancers, 2024 - mdpi.com
Simple Summary Molecular directed therapy for hepatocellular carcinoma (HCC) involves
targeting specific signaling pathways that normally promote cancer cell growth and survival …
targeting specific signaling pathways that normally promote cancer cell growth and survival …
Scalable and universal prediction of cellular phenotypes
Biological systems can be understood by perturbing individual components and studying the
system's response. Cell biology experiments are defined by the applied treatment, cellular …
system's response. Cell biology experiments are defined by the applied treatment, cellular …
Establishment and characterization of six canine hepatocellular carcinoma cell lines
JY Lee, K Bae, JH Kim, HJ Han, HY Yoon… - Frontiers in Veterinary …, 2024 - frontiersin.org
Background Hepatocellular carcinoma (HCC) is the most common malignant liver tumor in
dogs. Although surgical resection is a major treatment option for canine HCC, there are no …
dogs. Although surgical resection is a major treatment option for canine HCC, there are no …